Latest news, press releases, and SEC filings for Connect Biopharma Holdings Ltd (CNTB) https://caymanjournal.com/stock/CNTB en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:32:28 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is an SEC filing called an 8-K, which companies use to announce major news to investors. This specific filing includes a press release about a clinical trial update. It’s meant to keep the market informed about the progress of the company’s lead drug. 👉 **Why it mat https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000016 https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000016 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is an **8-K filing**, which is like a major news alert a public company sends to the SEC and investors. This specific one includes a **press release** (the exhibit) where Connect Biopharma reports its 2025 financial results and gives a big update on its business prog https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000012 https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000012 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **Securities Purchase Agreement** filed as an exhibit to an 8-K report. Think of it as the detailed contract for a **private investment deal**. Connect Biopharma is selling new shares directly to a group of investors (not on the public stock market) to raise mone https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000006 https://caymanjournal.com/stock/CNTB/sec-filing/0001835268-26-000006 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing